Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery

NCT00541086 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

3697

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: anastrozole
DRUG: exemestane
DRUG: letrozole
DRUG: tamoxifen citrate

Sponsor

Gruppo Italiano Mammella (GIM)